INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2014

A review notes standard drugs for bacterial vaginosis cure 65% to 85% of cases, highlighting potential roles for agents like vitamin C and probiotics.

This review examined literature from PubMed and Web of Science regarding therapeutic actions to cure, prevent, or delay recurrences of bacterial vaginosis (BV). Standard treatments (clindamycin and metronidazole) achieve complete cure in 65% to 85% of cases, though relapses are common within weeks to months. Emerging antibiotic and acidifying treatments such as vitamin C and lactic acid offer more options for combination therapies and prophylaxis. Adjuvant therapy with probiotics may also play a significant role in improving efficacy and preventing recurrences, though it is unlikely to replace antibiotherapy.

Study type
Literature review
Who was studied
Women with bacterial vaginosis
What was measured
Cure, prevention, and delay of recurrences of bacterial vaginosis

THE PAPER

Treatment of bacterial vaginosis: what we have and what we miss.

Donders GG, Zodzika J, Rezeberga D. Expert Opin Pharmacother, 2014.

PubMed 24579850 ↗DOI 10.1517/14656566.2014.881800 ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.